Unknown

Dataset Information

0

Spatial heterogeneity of extensively drug resistant-tuberculosis in Western Cape Province, South Africa.


ABSTRACT: Tuberculosis (TB) remains a leading infectious disease killer globally. Treatment outcomes are especially poor among people with extensively drug-resistant (XDR) TB, until recently defined as rifampicin-resistant (RR) TB with resistance to an aminoglycoside (amikacin) and a fluoroquinolone (ofloxacin). We used laboratory TB test results from Western Cape province, South Africa between 2012 and 2015 to identify XDR-TB and pre-XDR-TB (RR-TB with resistance to one second-line drug) spatial hotspots. We mapped the percentage and count of individuals with RR-TB that had XDR-TB and pre-XDR-TB across the province and in Cape Town, as well as amikacin-resistant and ofloxacin-resistant TB. We found the percentage of pre-XDR-TB and the count of XDR-TB/pre-XDR-TB highly heterogeneous with geographic hotspots within RR-TB high burden areas, and found hotspots in both percentage and count of amikacin-resistant and ofloxacin-resistant TB. The spatial distribution of percentage ofloxacin-resistant TB hotspots was similar to XDR-TB hotspots, suggesting that fluoroquinolone-resistace is often the first step to additional resistance. Our work shows that interventions used to reduce XDR-TB incidence may need to be targeted within spatial locations of RR-TB, and further research is required to understand underlying drivers of XDR-TB transmission in these locations.

SUBMITTER: Sy KTL 

PROVIDER: S-EPMC9237070 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9453078 | biostudies-literature
| S-EPMC7920662 | biostudies-literature
| S-EPMC6217717 | biostudies-literature
| S-EPMC5330208 | biostudies-literature
| S-EPMC6103505 | biostudies-literature
| S-EPMC6497867 | biostudies-other
| S-EPMC7894866 | biostudies-literature
| S-EPMC11337563 | biostudies-literature
| S-EPMC5124991 | biostudies-literature
| S-EPMC3647643 | biostudies-literature